Literature DB >> 36175802

Patient-clinician communication and patient-centered outcomes among patients with suspected stage I non-small cell lung cancer: a prospective cohort study.

Shannon M Nugent1,2,3, Sara E Golden4, Donald R Sullivan4,5,6, Charles R Thomas7,8, Juan Wisnivesky9, Somnath Saha4, Christopher G Slatore4,5,7,8,10.   

Abstract

Among patients with suspected early-stage non-small cell lung cancer (NSCLC), we sought to evaluate the association of patient-clinician communication (PCC) with patient-centered outcomes (PCOs). We conducted a multicenter, prospective cohort study examining PCOs at five time points, up to 12-months post-treatment. We used generalized estimating equation (GEE) models adjusted for sociodemographic and clinical variables to examine the relationship between PCC (dichotomized as high- or low-quality) and decisional conflict, treatment self-efficacy, and anxiety. The cohort included 165 patients who were 62% male with a mean age of 70.7 ± SD 8.1 years. Adjusted GEE analysis including 810 observations revealed high-quality PCC was associated with no decisional conflict (adjusted odds ratio [aOR] = 0.14, 95% CI = 0.07 to 0.27) and higher self-efficacy (β = -0.26, 95% CI = -0.37 to -0.14). High-quality PCC was not associated with moderately severe anxiety (aOR = 0.68, 95% CI = 0.41 to 1.09), though was associated with decreased anxiety scores (β = -3.91, 95% CI = -6.48 to -1.35). Among individuals with suspected early-stage NSCLC, high-quality PCC is associated with less decisional conflict and higher self-efficacy; the relationship with anxiety is unclear. Clinicians should prioritize enhanced treatment-related communication at critical and vulnerable periods in the cancer care trajectory to improve PCOs.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  Early-stage lung cancer; Patient-centered outcomes; Patient-clinician communication; Prospective cohort

Mesh:

Year:  2022        PMID: 36175802     DOI: 10.1007/s12032-022-01776-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.738


  35 in total

Review 1.  Endpoints in medical communication research, proposing a framework of functions and outcomes.

Authors:  Hanneke de Haes; Jozien Bensing
Journal:  Patient Educ Couns       Date:  2009-01-15

2.  Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant.

Authors:  Lisa M Wu; Jane Austin; Jada G Hamilton; Heiddis Valdimarsdottir; Luis Isola; Scott Rowley; Rachel Warbet; Gary Winkel; William H Redd; Christine Rini
Journal:  Psychooncology       Date:  2011-07-08       Impact factor: 3.894

3.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies.

Authors:  Alex J Mitchell; Melissa Chan; Henna Bhatti; Marie Halton; Luigi Grassi; Christoffer Johansen; Nicholas Meader
Journal:  Lancet Oncol       Date:  2011-01-19       Impact factor: 41.316

4.  Long-term outcomes of the FRESH START trial: exploring the role of self-efficacy in cancer survivors' maintenance of dietary practices and physical activity.

Authors:  Catherine E Mosher; Isaac Lipkus; Richard Sloane; Denise C Snyder; David F Lobach; Wendy Demark-Wahnefried
Journal:  Psychooncology       Date:  2012-04-30       Impact factor: 3.894

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

6.  A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.

Authors:  Christopher Cao; Daniel Wang; Caroline Chung; David Tian; Andreas Rimner; James Huang; David R Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2018-09-15       Impact factor: 5.209

Review 7.  SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

Authors:  Hanbo Chen; Alexander V Louie
Journal:  Curr Treat Options Oncol       Date:  2016-06

8.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Dual equipoise shared decision making: definitions for decision and behaviour support interventions.

Authors:  Glyn Elwyn; Dominick Frosch; Stephen Rollnick
Journal:  Implement Sci       Date:  2009-11-18       Impact factor: 7.327

10.  Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.

Authors:  Austin Lammers; Timur Mitin; Drew Moghanaki; Charles R Thomas; Robert Timmerman; Sara E Golden; Sujata Thakurta; Rafal Dziadziuszko; Christopher G Slatore
Journal:  Adv Radiat Oncol       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.